AN2 Therapeutics, Inc. Common Stock
ANTXAN2 Therapeutics, Inc. (ANTX) is a biopharmaceutical company focused on developing targeted therapies for neurodegenerative and neurological disorders. The company’s research centers on innovative approaches to treat diseases such as Alzheimer's and other cognitive impairments, aiming to address unmet medical needs through novel small molecule and biologic programs.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 1, 2018 | $0.66 | 2018-04-12 | 2018-04-15 |
| February 1, 2018 | $0.66 | 2018-01-11 | 2018-01-15 |
| November 1, 2017 | $0.66 | 2017-10-12 | 2017-10-15 |
| August 1, 2017 | $0.66 | 2017-07-12 | 2017-07-15 |
| May 1, 2017 | $0.66 | 2017-04-11 | 2017-04-15 |
Dividends Summary
- Consistent Payer: AN2 Therapeutics, Inc. Common Stock has rewarded shareholders with 12 dividend payments over the past 3 years.
- Total Returned Value: Investors who held ANTX shares during this period received a total of $7.79 per share in dividend income.
- Latest Payout: The most recent dividend of $0.66/share was paid 2824 days ago, on May 1, 2018.
- Yield & Schedule: ANTX currently pays dividends quarterly with an annual yield of 222.45%.
- Dividend Growth: Since 2015, the dividend payout has grown by 13.9%, from $0.58 to $0.66.
Company News
AN2 Therapeutics (ANTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for monday.com Ltd. (NASDAQ: MNDY) from $238 to $242. Keybanc analyst Jason Celino maintained an Overweight rating. monday.c...
U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightly lower on Monday. The Dow traded up 0.52% to 38,873.28 while the NASDAQ fell 0.10% to 15,975.16. The S&P 500 also rose, gaining, 0.12% to 5,032.46. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades' Leading and ...
Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and lowered its price target from $6 to $1. Big Lots shares dipped 31.3% to $3.6850 on Monday. Here are some other stocks moving in today's mid-day se...
U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday. The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500 also rose, gaining, 0.30% to 5,041.87. Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades' Leading and Lagging S...
